JDRF Study Results Show Continuous Glucose Monitoring Provides Significant
Benefits in Management of Type 1 DiabetesMonday September 8, 9:06 am ET
ROME--(BUSINESS WIRE)--New study data presented by the Juvenile
Diabetes Research Foundation (JDRF) today at the 44th annual meeting of the
European Association for the Study of Diabetes (EASD), showed the use of
Continuous Glucose Monitoring (CGM) to be effective in the management of Type 1
Highlights of the study results include:
- Patients 25 years of age or older who used CGM showed significant
improvement in glucose control as measured by HbA1c.
- Most importantly, this improvement in control was observed without an
increase in hypoglycemia (low blood sugar), which is a common concern in
intensively managed patients trying to achieve improved glucose control.
- In all ages, patients who used CGM at least six days a week had
substantially improved HbA1c levels.
Kerri maybe this will help with the insurance company.